BR112017015784A2 - composições dispersíveis - Google Patents

composições dispersíveis

Info

Publication number
BR112017015784A2
BR112017015784A2 BR112017015784-5A BR112017015784A BR112017015784A2 BR 112017015784 A2 BR112017015784 A2 BR 112017015784A2 BR 112017015784 A BR112017015784 A BR 112017015784A BR 112017015784 A2 BR112017015784 A2 BR 112017015784A2
Authority
BR
Brazil
Prior art keywords
compositions
dispersible compositions
useful
dispersible
pediatric
Prior art date
Application number
BR112017015784-5A
Other languages
English (en)
Other versions
BR112017015784B1 (pt
Inventor
Kumar Gupta Manish
Wasudeo MARATHE Shripad
Ramesh Tambwekar Kaustubh
Velayudhan NAIR Shreedevi
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR112017015784A2 publication Critical patent/BR112017015784A2/pt
Publication of BR112017015784B1 publication Critical patent/BR112017015784B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

a presente invenção diz respeito a composições dispersíveis compreendendo fumarato de bedaquilina como um ingrediente ativo. tais composições são úteis no tratamento da tuberculose e as suas propriedades de dispersibilidade inerentes se prestam a ser úteis em particular entre a população pediátrica ou geriátrica.
BR112017015784-5A 2015-01-27 2016-01-26 Comprimido e composição de comprimido, seu processo de preparação, e combinações compreendendo os mesmos BR112017015784B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN264MU2015 2015-01-27
IN264/MUM/2015 2015-01-27
PCT/EP2016/051545 WO2016120258A1 (en) 2015-01-27 2016-01-26 Dispersible compositions

Publications (2)

Publication Number Publication Date
BR112017015784A2 true BR112017015784A2 (pt) 2018-03-27
BR112017015784B1 BR112017015784B1 (pt) 2023-05-30

Family

ID=

Also Published As

Publication number Publication date
AU2016212116B2 (en) 2021-07-15
EP3250182B1 (en) 2023-04-26
EP3250182A1 (en) 2017-12-06
UA126891C2 (uk) 2023-02-22
HK1243644A1 (zh) 2018-07-20
SG11201705944TA (en) 2017-08-30
JP2021098706A (ja) 2021-07-01
HUE062481T2 (hu) 2023-11-28
DK3250182T3 (da) 2023-06-26
JP2018502928A (ja) 2018-02-01
JP2022176982A (ja) 2022-11-30
KR20170106447A (ko) 2017-09-20
IL310920A (en) 2024-04-01
RS64308B1 (sr) 2023-07-31
CN107205945A (zh) 2017-09-26
SI3250182T1 (sl) 2023-08-31
MX2017009681A (es) 2017-10-18
LT3250182T (lt) 2023-07-10
KR102631986B1 (ko) 2024-01-30
PH12017501331A1 (en) 2017-12-11
CN114129526A (zh) 2022-03-04
WO2016120258A1 (en) 2016-08-04
US20180000810A1 (en) 2018-01-04
MA41411B1 (fr) 2023-07-31
EA201791701A1 (ru) 2017-11-30
PT3250182T (pt) 2023-07-07
PL3250182T3 (pl) 2023-07-31
MD3250182T2 (ro) 2023-09-30
FI3250182T3 (fi) 2023-06-28
US20220331307A1 (en) 2022-10-20
AU2016212116A1 (en) 2017-07-27
CA2973301A1 (en) 2016-08-04
PE20171319A1 (es) 2017-09-07
IL253626B1 (en) 2024-04-01
AU2021204135B2 (en) 2023-10-05
IL253626A0 (en) 2017-09-28
JP7291458B2 (ja) 2023-06-15
AU2021204135A1 (en) 2021-07-15
HRP20230616T1 (hr) 2023-09-29
ES2948805T3 (es) 2023-09-19
CY1126107T1 (el) 2023-11-15
MA41411A (fr) 2017-12-05

Similar Documents

Publication Publication Date Title
EA201791701A1 (ru) Диспергируемые композиции
CY1122344T1 (el) Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων
EA201990043A1 (ru) Антибактериальные соединения
MX2022000056A (es) Peptidos anti-microbianos estabilizados.
PH12017502298A1 (en) Antibacterial compounds
BR112017024384A2 (pt) bactérias modificadas para reduzir hiperfenilalaninemia
EA201892431A1 (ru) Олигонуклеотиды для лечения заболевания глаз
MX2017001279A (es) Usos y composiciones de la flagelina.
GB2547402A (en) Prevention and treatment of microbial infections
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
EP4299122A3 (en) Compositions and methods for treating skin and mucous membrane diseases
CO2022000278A2 (es) Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella
TR201901077T4 (tr) Kanser Veya Enfeksiyon Tedavisine Yönelik Birleşik Preparasyonlar
AU2024202211A1 (en) Bisphosphocin gel formulations and uses thereof
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2019002924A (es) Composiciones purificadas de oligosacaridos de leche humana.
MX2020001885A (es) Formulaciones de daptomicina.
CY1124286T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
BR112017024908A2 (pt) usos terapêuticos da 4-cloroquinurenina
MX2019011613A (es) Formulaciones de acido 1-amino-1-ciclopropanocarboxilico.
MX362155B (es) Combinaciones de alquilamidotiazoles y sustancias aromaticas.
MX2018010264A (es) Formulaciones libres de solventes de sustancias activas de bajo punto de fusion.
WO2017123610A3 (en) Bacteria engineered to detoxify deleterious molecules
BR112019007564A2 (pt) composições dispersíveis
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/01/2016, OBSERVADAS AS CONDICOES LEGAIS

B17A Notification of administrative nullity (patentee has 60 days time to reply to this notification)

Free format text: REQUERENTE DA NULIDADE: ASSOCIACAO BRASILEIRA INTERDISCIPLINAR DE AIDS E ASSOCIACAO BRASILEIRA DE SAUDE COLETIVA (ABRASCO) - 870230105759 - 30/11/2023